ReviewJournal of clinical and experimental hematopathology : JCEH2025

Advances and future perspectives in chimeric antigen receptor T-cell and bispecific antibody therapies for multiple myeloma.

Tomotaka Suzuki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.